跳至主要内容
临床试验/JPRN-UMIN000020977
JPRN-UMIN000020977已完成1 期

preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 study - Preoperative chemoradiation therapy for pancreatic cancer

fukushima medical university0 个研究点目标入组 30 人开始时间: 2016年4月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) unresectable pancreatic cancer 1 distant organ metastasis 2 peritoneal dissamination 3 para aortic lymph node metastasis 4 pancreatic cancer with artery invasion, such as abdominal aorta, superior mesenteric artery, ceriac artery, common hepatic artery, or proper hepatic artery. 5 portal vein invasion beyond reconstruction patient with interstitial lung disease or fibroid lung patient with severe diarrhea active viral infection excluding viral hepatitis patient with double cancer a woman of childbearing potential patient with severe psychological disorder patient with severe allergy to any drug

研究者

相似试验